Literature DB >> 1362702

Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins.

G Bastian1, S Urien, F Brée, P Jolliet, I Rocher, O Crambes, J P Tillement.   

Abstract

The binding of racemic tertatolol and 4-hydroxytertatolol and of their enantiomers was compared in alpha 1-acid glycoprotein and albumin solutions. The binding rate of S(-)tertatolol to alpha 1-acid glycoprotein was much greater than that of R(+)tertatolol, the binding of the racemate being intermediate. It was the reverse for the binding to albumin, although the differences were slight. The binding of 4-hydroxytertatolol racemate and enantiomers was very low as compared to the binding of tertatolol, and there were no statistically significant differences in the binding of the 4-hydroxytertatolol enantiomers to either alpha 1-acid glycoprotein or albumin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362702     DOI: 10.1007/BF03190151

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration.

Authors:  S Urien; D Morin; A Renouard; I Rocher; J P Tillement
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  The stereoselectivity of the 'single drug binding site' of human alpha 1-acid glycoprotein (orosomucoid).

Authors:  F Brunner; W E Müller
Journal:  J Pharm Pharmacol       Date:  1987-12       Impact factor: 3.765

3.  Stereospecificity of beta-adrenoceptor blockade and renal vasodilatation by tertatolol.

Authors:  J F Smits; H H Zeegers; H A Struyker-Boudier
Journal:  Arch Int Pharmacodyn Ther       Date:  1989 Mar-Apr

4.  Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin.

Authors:  U K Walle; T Walle; S A Bai; L S Olanoff
Journal:  Clin Pharmacol Ther       Date:  1983-12       Impact factor: 6.875

5.  Multiple human serum binding of two thienopyridinic derivatives, ticlopidine and PCR 2362, and their distribution between HSA, alpha1-acid glycoprotein and lipoproteins.

Authors:  S Glasson; R Zini; J P Tillement
Journal:  Biochem Pharmacol       Date:  1982-03-01       Impact factor: 5.858

Review 6.  Biodisposition of tertatolol in man: a review.

Authors:  D B Campbell; J C Chignon; J P Devissaguet
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

7.  Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma.

Authors:  F Albani; R Riva; M Contin; A Baruzzi
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

8.  Stereoselective binding of disopyramide to human plasma protein.

Authors:  J J Lima; G L Jungbluth; T Devine; L W Robertson
Journal:  Life Sci       Date:  1984-08-20       Impact factor: 5.037

9.  Binding of indapamide to serum proteins and erythrocytes.

Authors:  S Urien; P Riant; A Renouard; B Coulomb; I Rocher; J P Tillement
Journal:  Biochem Pharmacol       Date:  1988-08-01       Impact factor: 5.858

10.  Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury.

Authors:  M Leeman; R Naeije; J P Degaute; F Brackman; J Thomas; J F Prost
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.